123 related articles for article (PubMed ID: 25004807)
1. Adhesion to type V collagen enhances staurosporine-induced apoptosis of adrenocortical cancer cells.
Nardo T; Micalizzi G; Vicinanza R; De Iuliis F; Taglieri L; Scarpa S
Tumour Biol; 2014 Oct; 35(10):9949-55. PubMed ID: 25004807
[TBL] [Abstract][Full Text] [Related]
2. Role of extracellular matrix in regulation of staurosporine-induced apoptosis in breast cancer cells.
Vasaturo F; Malacrino C; Sallusti E; Coppotelli G; Birarelli P; Giuffrida A; Albonici L; Simonelli L; Modesti A; Modesti M; Scarpa S
Oncol Rep; 2005 Apr; 13(4):745-50. PubMed ID: 15756452
[TBL] [Abstract][Full Text] [Related]
3. TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma.
Jain M; Zhang L; He M; Zhang YQ; Shen M; Kebebew E
Endocr Relat Cancer; 2013 Jun; 20(3):361-70. PubMed ID: 23533247
[TBL] [Abstract][Full Text] [Related]
4. Homeobox A5 activates p53 pathway to inhibit proliferation and promote apoptosis of adrenocortical carcinoma cells by inducing Aldo-Keto reductase family 1 member B10 expression.
Chen D; Shen Z; Cheng X; Wang Q; Zhou J; Ren F; Sun Y; Wang H; Huang R
Bioengineered; 2021 Dec; 12(1):1964-1975. PubMed ID: 34027794
[TBL] [Abstract][Full Text] [Related]
5. Co-inhibition of EGFR and IGF1R synergistically impacts therapeutically on adrenocortical carcinoma.
Xu L; Qi Y; Xu Y; Lian J; Wang X; Ning G; Wang W; Zhu Y
Oncotarget; 2016 Jun; 7(24):36235-36246. PubMed ID: 27105537
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor activity of staurosporine in the tumor microenvironment of cervical cancer: An in vitro study.
Yadav SS; Prasad CB; Prasad SB; Pandey LK; Singh S; Pradhan S; Narayan G
Life Sci; 2015 Jul; 133():21-8. PubMed ID: 26006035
[TBL] [Abstract][Full Text] [Related]
7. cAMP-dependent protein kinase activation inhibits proliferation and enhances apoptotic effect of tumor necrosis factor-alpha in NCI-H295R adrenocortical cells.
Liu J; Li XD; Ora A; Heikkilä P; Vaheri A; Voutilainen R
J Mol Endocrinol; 2004 Oct; 33(2):511-22. PubMed ID: 15525605
[TBL] [Abstract][Full Text] [Related]
8. IGF2 role in adrenocortical carcinoma biology.
Pereira SS; Monteiro MP; Costa MM; Moreira Â; Alves MG; Oliveira PF; Jarak I; Pignatelli D
Endocrine; 2019 Nov; 66(2):326-337. PubMed ID: 31378849
[TBL] [Abstract][Full Text] [Related]
9. Loss of β-catenin in adrenocortical cancer cells causes growth inhibition and reversal of epithelial-to-mesenchymal transition.
Salomon A; Keramidas M; Maisin C; Thomas M
Oncotarget; 2015 May; 6(13):11421-33. PubMed ID: 25823656
[TBL] [Abstract][Full Text] [Related]
10. MAPK/ERK pathway inhibition is a promising treatment target for adrenocortical tumors.
Pereira SS; Monteiro MP; Costa MM; Ferreira J; Alves MG; Oliveira PF; Jarak I; Pignatelli D
J Cell Biochem; 2019 Jan; 120(1):894-906. PubMed ID: 30256438
[TBL] [Abstract][Full Text] [Related]
11. In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures
Fragni M; Palma Lopez LP; Rossini E; Abate A; Cosentini D; Salvi V; Vezzoli S; Poliani PL; Bosisio D; Hantel C; Tiberio GAM; Grisanti S; Memo M; Terzolo M; Berruti A; Sigala S
Mol Cell Endocrinol; 2019 Dec; 498():110585. PubMed ID: 31536779
[TBL] [Abstract][Full Text] [Related]
12. Enhanced ERK dependent CREB activation reduces apoptosis in staurosporine-treated human neuroblastoma SK-N-BE(2)C cells.
Park EM; Cho S
Neurosci Lett; 2006 Jul; 402(1-2):190-4. PubMed ID: 16678346
[TBL] [Abstract][Full Text] [Related]
13. Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.
Altieri B; Sbiera S; Della Casa S; Weigand I; Wild V; Steinhauer S; Fadda G; Kocot A; Bekteshi M; Mambretti EM; Rosenwald A; Pontecorvi A; Fassnacht M; Ronchi CL
Oncotarget; 2017 Feb; 8(6):9323-9338. PubMed ID: 28030838
[TBL] [Abstract][Full Text] [Related]
14. Silencing mutated β-catenin inhibits cell proliferation and stimulates apoptosis in the adrenocortical cancer cell line H295R.
Gaujoux S; Hantel C; Launay P; Bonnet S; Perlemoine K; Lefèvre L; Guillaud-Bataille M; Beuschlein F; Tissier F; Bertherat J; Rizk-Rabin M; Ragazzon B
PLoS One; 2013; 8(2):e55743. PubMed ID: 23409032
[TBL] [Abstract][Full Text] [Related]
15. C-MYC modulation induces responsiveness to paclitaxel in adrenocortical cancer cell lines.
Cerquetti L; Sampaoli C; De Salvo M; Bucci B; Argese N; Chimento A; Vottari S; Marchese R; Pezzi V; Toscano V; Stigliano A
Int J Oncol; 2015 May; 46(5):2231-40. PubMed ID: 25708932
[TBL] [Abstract][Full Text] [Related]
16. Rottlerin as a novel chemotherapy agent for adrenocortical carcinoma.
Zhu Y; Wang M; Zhao X; Zhang L; Wu Y; Wang B; Hu W
Oncotarget; 2017 Apr; 8(14):22825-22834. PubMed ID: 28423559
[TBL] [Abstract][Full Text] [Related]
17. Metformin as a new anti-cancer drug in adrenocortical carcinoma.
Poli G; Cantini G; Armignacco R; Fucci R; Santi R; Canu L; Nesi G; Mannelli M; Luconi M
Oncotarget; 2016 Aug; 7(31):49636-49648. PubMed ID: 27391065
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis by staurosporine involves the inhibition of expression of the major cell cycle proteins at the G(2)/m checkpoint accompanied by alterations in Erk and Akt kinase activities.
Antonsson A; Persson JL
Anticancer Res; 2009 Aug; 29(8):2893-8. PubMed ID: 19661292
[TBL] [Abstract][Full Text] [Related]
19. Stathmin decreases cholangiocarcinoma cell line sensitivity to staurosporine-triggered apoptosis via the induction of ERK and Akt signaling.
Wang Y; Gao Z; Zhang D; Bo X; Wang Y; Wang J; Shen S; Liu H; Suo T; Pan H; Ai Z; Liu H
Oncotarget; 2017 Feb; 8(9):15775-15788. PubMed ID: 28178656
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of parathyroid hormone-related protein in adrenocortical tumors: autocrine/paracrine effects on the growth and signaling pathways in H295R cells.
Rizk-Rabin M; Assie G; Rene-Corail F; Perlemoine K; Hamzaoui H; Tissier F; Lieberherr M; Bertagna X; Bertherat J; Bouizar Z
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2275-85. PubMed ID: 18768493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
